Please assess the completion status of the following clinical trial:

Trial Title: Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: None
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Diagnosis of cancer~* Concurrently receiving or has previously received chemotherapy and is scheduled for at least 3 additional courses of chemotherapy~  * Each course of chemotherapy must be at least 2 weeks in duration~ * No concurrent radiotherapy or interferon therapy~* Brief Fatigue Inventory question #3 fatigue worst score of 2 or greater 1 week after first chemotherapy course~PATIENT CHARACTERISTICS:~Age~* 18 and over~Performance status~* Not specified~Life expectancy~* At least 6 months~Hematopoietic~* Not specified~Hepatic~* No uncontrolled anemia~Renal~* Not specified~Cardiovascular~* No history of clinically significant cardiac disease, including any of the following:~  * Unstable angina~ * Left ventricular hypertrophy~ * Ischemic echocardiogram changes~ * Chest pain~ * Arrhythmia~ * Other clinically significant manifestations of mitral valve prolapse in association with use of central nervous system stimulants (e.g., caffeine, amphetamines, or methylphenidate)~* No uncontrolled hypertension~Gastrointestinal~* Able to swallow medication~* No narrowing (pathological or iatrogenic) or obstruction of the gastrointestinal tract~Other~* No severe headaches~* No glaucoma~* No seizure disorder~* No narcolepsy~* No psychotic disorder~* No Tourette's syndrome~* No alcohol or drug abuse~* Not pregnant or nursing~* Fertile patients must use effective barrier contraception during and for at least 1 full menstrual cycle after study completion~PRIOR CONCURRENT THERAPY:~Biologic therapy~* See Disease Characteristics~Chemotherapy~* See Disease Characteristics~Endocrine therapy~* No concurrent chronic corticosteroids~Radiotherapy~* See Disease Characteristics~Surgery~* Not specified~Other~* No prior modafinil~* At least 30 days since prior regular use of psychostimulants (e.g., amphetamines, methylphenidate, or pemoline) or monoamine oxidase inhibitors (MAOIs)~* No concurrent alcohol~* Concurrent acetaminophen with codeine or hydrocodone bitartrate allowed~* Concurrent phenytoin allowed~* Concurrent warfarin for anticoagulation and low-dose warfarin (1 mg by mouth daily) for maintenance of venous access devices allowed

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 120 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).